We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

LGC Clinical Diagnostics

LGC Clinical Diagnostics is a leading provider of Quality Measurement Tools, biological materials, and reagents for t... read more Featured Products: More products

Download Mobile App





LGC Clinical Diagnostics Demonstrates How Labs Can Enhance QC Efficiencies at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 06 Feb 2023
Print article
Image: Multichem is a class leading, third-party, test-consolidated QC product range (Photo courtesy of LGC)
Image: Multichem is a class leading, third-party, test-consolidated QC product range (Photo courtesy of LGC)

LGC Clinical Diagnostics (Middlesex, UK) is attending Medlab Middle East 2023 where it is demonstrating how laboratories can enhance their quality control (QC) efficiencies through automated processes with independent QC and QC data management.

Under LGC Clinical Diagnostics Group, the company’s booth at this year’s Medlab Middle East is representing the combined brands: Maine Standards, SeraCare, Technopath Clinical Diagnostics, and The Native Antigen Company. LGC is presenting its comprehensive portfolio of catalogue and custom-developed diagnostic quality solutions and component materials with representatives from each company available to answer all the questions of visitors at its booth.

At Medlab Middle East 2023, LGC is showcasing Technopath’s total QC solution, Multichem QC and IAMQC software that provide clinical laboratories with significant cost, handling and time savings, whilst delivering higher confidence in analytical testing methods. With an extensive list of analytes included in the Multichem range of QC products, choice and flexibility are guaranteed for all customers. The third party QC products include General Clinical Chemistry, Immunoproteins, Immunoassay, Cardiac, Urine Chemistry, Infectious Disease, Diabetes and other Esoteric controls. The controls are offered in assayed and unassayed formats. Technopath’s human based control matrix offers unrivalled test consolidation through increased control stability and diminished matrix effects. Together, these aspects of control manufacture offer greater control efficiencies without compromising compliance or confidence in patient results.

LGC is also demonstrating the IAMQC Software from Technopath that provides laboratory managers and technologists with a range of QC software tools to analyze their QC results in real-time. IAMQC Software tools allow users to automate, centralize, standardize and improve QC processes in a laboratory setting. A combination of modules satisfies the varying levels of QC requirements in individual laboratories and is easily tailored to meet different QC management expectations. This also includes the new IAMQC Infinity that incorporates all the functionality of IAMQC Peer, Daily and Expert in one application. The powerful cloud based software designed to exactly meet specific QC solution needs has a feature-based interface that allows the laboratory to build their custom solution and then to seamlessly add in further sophisticated features as and when needed.

Related Links:
LGC

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Lyme Disease Test
Lyme IgG/IgM Rapid Test Cassette
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The study validated the Lumipulse p-tau21 automated and scalable blood test system (Photo courtesy of Fujirebio)

Blood Test for Early Alzheimer's Detection Achieves Over 90% Accuracy

Alzheimer's disease (AD) is a debilitating condition and a leading cause of disability and death worldwide. The availability of reliable diagnostic tools is currently restricted, and diagnosis often relies... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.